Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
An overview of M&A trends for the top 150 global pharmaceutical companies during 2008 and 2009 with discussion of the drivers of recent deals, plus case study analysis of key M&As.
Published By Datamonitor
|
17 Dec 2009 |
$11400
|
Report
|
Datamonitor’s report 5EU: Pricing, Reimbursement, and Regulatory Update provides an overview of developments regarding healthcare reforms, drug regulation, and drug pricing and reimbursement in France, Germany, Italy, Spain, and the UK.
Published By Datamonitor
|
28 Oct 2011 |
$1900
|
Report
|
Overview of the Australian pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
29 Jul 2010 |
$7600
|
Report
|
A historical (02-08) and forecast (08-14) sales overview of the PharmaVitae universe by drug delivery classification.
Published By Datamonitor
|
22 Dec 2009 |
$7600
|
Report
|
Revenue and financial performance analysis of the 22 largest Big Pharma M&A events since 1995.
Published By Datamonitor
|
10 Dec 2009 |
$7600
|
Report
|
A comparative analysis of leading pharmaceutical company sales dynamics over the period 200514
Published By Datamonitor
|
27 Nov 2009 |
$7600
|
Report
|
Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key biogeneric players and future development trends.
Published By Datamonitor
|
22 Sep 2011 |
$1900
|
Report
|
Biosimilars: India Update provides analysis on the Indian copy biologics market. It includes an overview of drivers and resistors to biologic uptake, market access strategies, key domestic biologic players and future development trends.
Published By Datamonitor
|
14 Oct 2011 |
$1900
|
Report
|
Datamonitor’s report Biosimilars: Japan Update provides analysis on the Japanese biosimilars market. It includes an overview of drivers and resistors to biosimilars uptake, market access strategies, key players, and future development trends.
Published By Datamonitor
|
13 Sep 2011 |
$1900
|
Exclusive online offer: order this report by November 9th and save 20%
To take advantage of this offer enter Promo Code BIO2012 when prompted in the checkout
More information
|
Report
|
This report provides an analysis of strategies employed by the top 50 pharma companies that are active or plan to enter the biosimilars sector in the future, together with an analysis of biosimilar deal trends among the top 50 pharma companies.
Published By Datamonitor
|
20 Dec 2011 |
$5700
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.